Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Prev Med Hyg ; 61(4): E497-E500, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33628952

ABSTRACT

In March 2020, the COVID-19 pandemic disrupted most of the routine outpatient activities in Italian hospitals and Prevention Departments, including those vaccinations which were not urgent and/or scheduled for children aged 0-6 years. Since June 2020, when the pandemic entered a milder phase, in the alpine Province of Belluno (Veneto, North-Eastern Italy), 12,152 doses of vaccine against tick-borne encephalitis have been administered by means of the innovative "drive-through" modality. No significant adverse events have occurred and popular demand has steadily grown, proving the "drive-through" approach to be safe, efficient and successful.


Subject(s)
COVID-19/epidemiology , Encephalitis, Tick-Borne/prevention & control , Vaccination/statistics & numerical data , Viral Vaccines/administration & dosage , Ambulatory Care Facilities/organization & administration , Child , Child Welfare/statistics & numerical data , Encephalitis, Tick-Borne/immunology , Humans , Italy
2.
Eur J Pharm Biopharm ; 146: 143-149, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31726217

ABSTRACT

Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug (NSAID) commonly used in the treatment of pain, fever and inflammation. However, the administration of IBU in its free carboxylic acid form is strongly dependent on its limited solubility in aqueous solution. This mandates for an increased drug concentration to reach the therapeutic window, and promotes the alternative use of IBU sodium salt, even if this latter form poses significant constraints in terms of tunable release due to its uncontrolled and rapid diffusion. A potential solution is represented by oral administration through physical encapsulation of ibuprofen in designed carriers, despite this route limits the application of this therapeutic agent. In this work, we propose the covalent tethering of ibuprofen to a hydrogel matrix via esterification reaction. Exploiting the cleavability of the ester bond under physiological conditions, we propose a controlled drug delivery system where the whole drug payload can be released, thus overcoming the questioned aspects of over-dosage and solubility-dependent administration. In particular, we tested the biological activity of cleaved ibuprofen in terms of cyclooxygenase inhibition, reporting that chemical tethering did not alter the efficiency of the NSAID. Moreover, due to the sol-gel transition of the hydrogel matrix, these ibuprofen-functionalized hydrogels could be used as injectable tools in several clinical scenarios, performing a localized drug release and opening advanced avenues for in situ treatments.


Subject(s)
Cyclooxygenase Inhibitors/pharmacokinetics , Drug Carriers/chemistry , Hydrogels/chemistry , Ibuprofen/pharmacokinetics , Acrylic Resins/chemistry , Administration, Oral , Cell Line, Tumor , Cyclooxygenase Inhibitors/administration & dosage , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/pharmacokinetics , Drug Liberation , Enzyme Assays , Humans , Ibuprofen/administration & dosage , Propylene Glycols/chemistry , Prostaglandin-Endoperoxide Synthases/metabolism , Sepharose/chemistry , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...